Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

Bibliographic Details
Main Authors:	Yuka Shibata, Hideki Nakajima, Kimiko Nakajima, Satoshi Serada, Minoru Fujimoto, Tetsuji Naka, Shigetoshi Sano
Format:	Article
Language:	English
Published:	Wiley 2021-08-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12174

Similar Items

Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study.
by: Takaaki Ishida, et al.
Published: (2020-01-01)

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma.
by: Hiromi Honda, et al.
Published: (2016-01-01)

Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells
by: Hayato Urushima, et al.
Published: (2017-06-01)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection.
by: Etsuko Kajimoto, et al.
Published: (2020-01-01)

Serum Leucine-Rich α2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis
by: Masaki Shimizu, et al.
Published: (2019-01-01)

Beneficial Impact of Apremilast on Palmoplantar Keratodermas
by: Kimiko Nakajima, et al.
Published: (2021-04-01)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
by: Hong Ma, et al.
Published: (2021-01-01)

Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
by: Yi Yang, et al.
Published: (2020-04-01)

Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.
by: Lawrence J Druhan, et al.
Published: (2017-01-01)

Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex.
by: Masakazu Miyajima, et al.
Published: (2013-01-01)

Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
by: Yongmei Han, et al.
Published: (2016-01-01)

Leucine-Rich α-2-Glycoprotein 1 Suppresses Endothelial Cell Activation Through ADAM10-Mediated Shedding of TNF-α Receptor
by: Kuin Tian Pang, et al.
Published: (2021-07-01)

Diagnostic performances of leucine-rich α-2-glycoprotein 1 and stem cell factor for diagnosis and follow-up of colorectal cancer
by: Manar S. Fouda, et al.
Published: (2021-01-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
by: Ingrid J. Guldvik, et al.
Published: (2020-10-01)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
by: Andersen John D, et al.
Published: (2010-09-01)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
by: Eriko Yasutomi, et al.
Published: (2021-05-01)

Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice
by: Sona haku, et al.
Published: (2018-01-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases
by: Minoru Fujimoto, et al.
Published: (2010-01-01)

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
by: Zhang Q, et al.
Published: (2018-05-01)

Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
by: Yuka Shibata, et al.
Published: (2021-08-01)

Paradoxical Roles of Leucine-Rich α2-Glycoprotein-1 in Cell Death and Survival Modulated by Transforming Growth Factor-Beta 1 and Cytochrome c
by: Ronald Jemmerson
Published: (2021-10-01)

Early psoriatic arthritis
by: E. Y. Loginova, et al.
Published: (2008-12-01)

IMAGING OF PSORIATIC ARTHRITIS
by: S. D'Angelo, et al.
Published: (2011-09-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
by: P.S. Helliwell
Published: (2011-09-01)

Epidemiology of psoriatic arthritis
by: C. Salvarani, et al.
Published: (2012-06-01)

The genetics of psoriatic arthritis
by: Ho, Pauline Y. P. Dr
Published: (2007)

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
by: Tetsuhiro Yoshimura, et al.
Published: (2021-01-01)

Studies of leucine-rich repeats and a novel, Drosophila, embryonic leucine-rich repeat protein
by: Buchanan, Sean G. St C.
Published: (1996)

THE FREQUENCY OF PSORIATIC ARTHRITIS IN PSORIATIC PATIENTS IN SULAIMANIA CITY
by: Raof R. Mirza, et al.
Published: (2011-12-01)

Diagnostic accuracy of Leucine-rich α-2 glycoprotein (LRG) as a urinary biomarker in pediatric appendicitis: a prospective observational pilot study from Eastern India
by: Santosh Kumar Mahalik, et al.
Published: (2021-06-01)

Serum and Urine Biomarker Leucine-Rich Alpha-2 Glycoprotein 1 Differentiates Pediatric Acute Complicated and Uncomplicated Appendicitis
by: Mohit Kakar, et al.
Published: (2021-05-01)

Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis
by: C. Salvarani, et al.
Published: (2004-09-01)

Cardiovascular risk factors in psoriatic disease: psoriasis psoriatic arthritis
by: Nuria Barbarroja, et al.
Published: (2019-10-01)

Prevalence of Psoriatic Arthritis among Psoriatic Patients in Damietta Governorate
by: Aisha Mohamed, et al.
Published: (2019-10-01)

Standards of therapy of psoriatic arthritis
by: T V Korotaeva, et al.
Published: (2009-06-01)

Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Management of patients with psoriatic arthritis
by: Yulia Leonidovna Korsakova
Published: (2012-03-01)